CBDG.US THC Farmaceuticals Inc
- Market cap
- USD 181K
- P/E
- -
- P/B
- 7.46x
- ROE
- -0.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Sep 2025.
Is CBDG.US undervalued?
Graham numberThe Graham number of THC Farmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
THC Farmaceuticals Inc fundamental analysis
No fundamental analysis for THC Farmaceuticals Inc yet.
THC Farmaceuticals Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About THC Farmaceuticals Inc
THC Farmaceuticals, Inc. owns and operates non-financial institution cash-dispensing automated teller machines at third-party owned retail and commercial locations. The company's machines are placed in hotels, stores, bowling alleys, and other high customer traffic areas for small and medium sized businesses. As of June 30, 2015, it had a total of eight machines for public use along the Wasatch Front in the State of Utah. The company was formerly known as City Media, Inc. an…
Full company profileTHC Farmaceuticals Inc financial statements
THC Farmaceuticals Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2014 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 19.03 | 17.1K | 12.9K | 12.2K | 10.2K | 7.58K | 2.23K | 10.0K | - | - |
| Gross Profit | 6.73 | 17.1K | 12.9K | 12.2K | 7.56K | 7.58K | 1.28K | 6.19K | -4.95K | -4.95K |
| Operating Income | -24.02 | -136K | -7.30K | -15.2K | -158K | -32.7K | -17.8K | -8.49K | -30.0K | -20.8K |
| EBITDA | -23.4K | -136K | -6.70K | -14.3K | -994K | -120K | -15.9K | 430K | -25.0K | -15.8K |
| Net Income | -30.70 | -136K | -7.30K | -15.2K | -499K | -60.4K | -8.42K | 427K | -15.0K | -10.4K |
| EPS | 0.00 | -0.01 | 0.00 | 0.00 | -0.03 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 48.15 | 1.75M | 1.75M | 2.75M | 2.53M | 2.33M | 2.80M | 2.78M | 2.75M | 2.72M |
| Total Liabilities | 96.17 | 953K | 960K | 959K | 1.09M | 551K | 588K | 142K | 142K | 142K |
| Shareholders' Equity | -48.02 | 800K | 792K | 1.81M | 1.96M | 2.35M | 2.79M | 3.22M | 3.20M | 3.19M |
| Cash & Short-term Investments | 0.64 | 1.71K | 1.71K | 31.7K | 2.55K | 2.59K | 18.8K | 1.71K | 1.71K | - |
| Total Debt | 77.70 | 908K | 915K | 917K | 917K | 343K | 373K | 142K | 142K | 115K |
| Cash Flow | ||||||||||
| Operating Cash Flow | -18.90 | -170K | -7.00K | -9.15K | -134K | -2.21K | -11.8K | 318K | 636K | - |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 5.00 | 3.00 | - |
| Free Cash Flow | -18.90 | -170K | -7.00K | -9.15K | -134K | -2.21K | -11.8K | 318K | 636K | - |
| Ratios | ||||||||||
| ROE | - | -17.0% | -0.9% | -0.8% | -25.5% | -2.6% | -0.3% | 13.3% | -0.5% | -0.3% |
| ROA | -63.8% | -7.8% | -0.4% | -0.6% | -19.7% | -2.6% | -0.3% | 15.4% | -0.5% | -0.4% |
| Net Profit Margin | -161.3% | -797.3% | -56.4% | -124.9% | -4,891.3% | -798.0% | -376.9% | 4,269.1% | - | - |
| Debt to Equity | - | 1.14x | 1.15x | 0.51x | 0.47x | 0.15x | 0.13x | 0.04x | 0.04x | 0.04x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
THC Farmaceuticals Inc dividends
THC Farmaceuticals Inc has not paid dividends in the last 10 fiscal years.
Who owns THC Farmaceuticals Inc
Ownership data of THC Farmaceuticals Inc is not available yet.
THC Farmaceuticals Inc company profile
- Company name
- THC Farmaceuticals Inc
- Ticker
- CBDG.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Fiscal year end
- September
- Address
- 7170 East McDonald Drive, Scottsdale, AZ, United States, 85253
- Phone
- 480-725-9060
- Website
- thcpharmaceuticals.com
About THC Farmaceuticals Inc
THC Farmaceuticals, Inc. owns and operates non-financial institution cash-dispensing automated teller machines at third-party owned retail and commercial locations. The company's machines are placed in hotels, stores, bowling alleys, and other high customer traffic areas for small and medium sized businesses. As of June 30, 2015, it had a total of eight machines for public use along the Wasatch Front in the State of Utah. The company was formerly known as City Media, Inc. and changed its name to THC Farmaceuticals, Inc. in February 2015. THC Farmaceuticals, Inc. was founded in 2008 and is based in Scottsdale, Arizona. THC Farmaceuticals, Inc. operates as a subsidiary of Weed Growth Fund, Inc.
THC Farmaceuticals Inc management
1- Mr. Ed RosenthalPresident